Compare DexCom, Inc. (DXCM) vs LYFT Inc (LYFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs LYFT Inc — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while LYFT Inc trades at $16.22 (market cap $6.11B). The key difference: DexCom, Inc. is far larger — about 5.2× LYFT Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, LYFT Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and LYFT Inc for 47 Days on average.
| DXCM | LYFT | |
|---|---|---|
Market Cap | $31.86B | $6.11B |
Volume | 3,607,070 | 13,504,560 |
Sector | Health | Technology |
52-Week High | $92.34 | $24.57 |
52-Week Low | $54.84 | $12.65 |
Typical Hold Time | 62 Days | 47 Days |
Enterprise Value | $31.32B | $5.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth from $2.9B in 2022 to $4.66B in 2025. Profit margins have expanded significantly to 17.93%, while analyst sentiment remains overwhelmingly positive with 81% buy ratings. Recent news highlights the company's focus on Type 2 diabetes market expansion and leadership appointments.
DXCM presents a compelling growth story with expanding profitability and market opportunities, though elevated valuation multiples and technical bearish signals warrant caution. The consensus price target of $95.07 suggests 13% upside potential, but investors should monitor competitive pressures and reimbursement challenges in the CGM market.
Lyft (LYFT) trades at $16.13, up 3.4% on the day, with a bullish technical signal and strong cash flow growth. The stock shows a low P/E of 2.35 and P/S of 0.96, while recent earnings have been mixed with two misses but a significant beat in Q4 2025. The company expanded into Europe and settled a major lawsuit, signaling operational momentum amid a volatile ride-hailing market.
Lyft presents a value opportunity with robust profitability margins and positive net income, though near-term risks include competitive pressures and reliance on earnings beats to sustain momentum. The consensus price target of $18.07 suggests modest upside, but investor sentiment remains cautious pending consistent execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →
